Streck EU patent infringement v. Cenata (Roche)

La Vista, NE – On December 21, 2018, the German District Court in Mannheim decided that Cenata GmbH (Cenata) infringed the Streck European Patent No. 2228453B1. The lawsuit accused patent infringement based upon Cenata activities in noninvasive prenatal testing (NIPT) involving the Harmony® Test, which is described as a Roche product. Cenata has appealed.

In the meantime, on March 7, 2019, the European Patent Office (“EPO”) upheld the Streck infringed patent, in an appealable Opposition Proceeding decision, in the face of validity attacks filed by both Roche (through Roche Diagnostic GmbH) and Cenata.

Streck is a leading European supplier of direct-draw blood collection tubes (BCT) used in NIPT, a new standard for pre-natal screening. One Streck BCT product, its Cell-Free DNA BCT® CE tube, has been available in the European Union countries since 2014. According to Connie Ryan, Streck CEO, “The separate decisions by the Mannheim Court and the EPO each reinforce the value of the Streck proprietary technologies and that infringement will not be tolerated.” CEO Ryan also said, “Though Cenata has appealed the Mannheim Court decision, and an appeal is expected in the EPO proceeding, Streck is confident the decisions will be upheld, and plans to pursue the full extent of available Court remedies.”

About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Streck is additionally a global manufacturer and supplier of hematology controls. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products in development for the growing field of molecular diagnostics.